Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion
Clinical trial NCT05565014 · UNKNOWN
Trial details
- NCT number
- NCT05565014
- Sponsor
- Sheng Hu
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2023-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.